Home Cart Sign in  
Chemical Structure| 1013920-15-4 Chemical Structure| 1013920-15-4

Structure of Vorolanib
CAS No.: 1013920-15-4

Chemical Structure| 1013920-15-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Vorolanib (CM082) is an orally active, potent VEGFR/PDGFR/DHODH inhibitor.

Synonyms: CM082; X-82; Vorolanib, CM-082, X-82, CM082, X82, CM 082, X 82

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Vorolanib

CAS No. :1013920-15-4
Formula : C23H26FN5O3
M.W : 439.48
SMILES Code : O=C(C1=C(C)NC(/C=C2C(NC3=C\2C=C(F)C=C3)=O)=C1C)N[C@@H]4CN(C(N(C)C)=O)CC4
Synonyms :
CM082; X-82; Vorolanib, CM-082, X-82, CM082, X82, CM 082, X 82
MDL No. :MFCD31382354

Safety of Vorolanib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Vorolanib

RTK

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT04222842 Myopic Choroidal Neovascularis... More >>ation Less << PHASE1 SUSPENDED 2021-12-30 Peking Union Medical College H... More >>ospital, Beijing, China Less <<
NCT03710863 Age-Related Macular Degenerati... More >>on Less << PHASE2 UNKNOWN 2022-01-01 Renmin Hospital of Wuhan Unive... More >>rsity, Hubei General Hospital, Wuhan, Hubei, 430060, China Less <<
NCT03792958 Advanced Malignant Solid Tumor... More >>s Less << PHASE1 UNKNOWN 2025-06-23 Shanghai East Hospital, Shangh... More >>ai, Shanghai, 200120, China Less <<
NCT01296581 Advanced Solid Tumors PHASE1 COMPLETED 2025-01-17 Sarah Cannon Research Institut... More >>e, Nashville, Tennessee, 37203, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.28mL

0.46mL

0.23mL

11.38mL

2.28mL

1.14mL

22.75mL

4.55mL

2.28mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
 

Historical Records

Categories